hrp0097p1-136 | Multisystem Endocrine Disorders | ESPE2023

Endocrinopathies in Congenital Disorder of Glycosylation (CDG): Short stature and hypergonadotropic hypogonadism are the main endocrinological manifestations in two unrelated cases of PMM2-CDG.

Del Medico Giulia , Procopio Elena , Ferri Lorenzo , Annibalini Giosuè , Morrone Amelia , Stagi Stefano , Barbieri Elena

Introduction: PMM2-CDG is the most common congenital disorder of glycosylation (CDG). Since glycoproteins are involved in every endocrine axis, PMM2-CDG patients have a high risk of developing endocrinopathies.Case report: We describe two 12 years-old female PMM2-CDG patients with severe short stature and no clinical sign of puberty. One patient showed low serum levels of insulin-like growth factor-1 (IGF-1) and IGF bind...

hrp0098rfc13.6 | Pituitary, Neuroendocrinology and Puberty 2 | ESPE2024

Hypogonadism hyperprolactinemia-related and its treatment in three patients with inherited disorders of biogenic amine metabolism

Soldovieri Sara , Trinati Eugenio , Corbelli Laura , Pontone Matteo , Cerutti Matteo , Rossi Alessio , Barbato Alessandro , Pochiero Francesca , Procopio Elena , Messa Federica , Stagi Stefano

Inherited disorders of biogenic amine metabolism are rare neurometabolic disorders caused by defects in neurotransmitters (dopamine, serotonin, norepinephrine, epinephrine). Dopamine deficiency leads to hyperprolactinemia. Prolactin blood level is used as peripheral indirect biomarker of central dopamine deficiency and can help in adjusting the therapy dosage, which primarily consists of using L-dopa. However, patients may become refractory to L-dopa and they could present hyp...